Modal close

Dear Democracy Now! visitor,

You turn to Democracy Now! for ad-free news you can trust. Maybe you come for our daily headlines. Maybe you come for in-depth stories that expose corporate and government abuses of power. Democracy Now! brings you crucial reporting like our coverage from the front lines of the standoff at Standing Rock or news about the movements fighting for peace, racial and economic justice, immigrant rights and LGBTQ equality. We produce our daily news hour at a fraction of the budget of a commercial news operation—all without ads, government funding or corporate sponsorship. How is this possible? Only with your support. Right now, a generous funder will match your donation dollar for dollar. That means when you give $10 to Democracy Now!, we'll receive $20. So, if you've been waiting to make your contribution to Democracy Now!, today is your day. It takes just a couple of minutes to make sure that Democracy Now! is there for you and everybody else in 2017.

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Topics

What Do Monsanto, Exxon-Mobil, Dow Chemical and Pfizer Have in Common? They Fund the Research for a Man Bush Has Nominated to Oversee Government Regulations

StoryMay 15, 2001
Watch iconWatch Full Show

White House officials and prominent conservatives say that President Bush is quietly building the most conservativeadministration in modern times, surpassing even Ronald Reagan in the ideological commitment of his appointments.

The appointments have come as a surprise even to conservative leaders, who expected Bush, particularly after thedisputed presidential election, to follow a centrist path closer to his father’s. The Washington Post quotedPaul Weyrich, President of the Free Congress Foundation, as saying: "This administration is shaping up to be thebest. When Reagan ran for office, even when Nixon ran, it was the campaign that was lovey-dovey. Then, when theygot in, they didn’t know who you were. Here, the Bush campaign didn’t pay any attention to us, but as soon as theygot in, they started taking notice. This is something that I’ve never experienced before."

The process continues this Thursday, when the Senate Governmental Affairs Committee will hold confirmation hearingsfor one of the more obscure–but one of the most critical–posts in the Bush administration.

That job is Administrator of the Office of Information and Regulatory Affairs (OIRA), within the Office of Managementand Budget (OMB). This is the administration’s regulatory gatekeeper, which wields the power to block anysignificant new safeguard proposed by a federal agency.

President Bush has nominated John Graham to fill this position. John Graham is currently the president of theHarvard center for Risk Analysis at the Harvard School of Public Health, which is funded by over 100 largecorporation and trade groups, including Monsanto, Exxon-Mobile, Shell Oil, the American Petroleum Institute, DowChemical, the Chemical Manufacturer’s Association, Coca-Cola, pharmaceutical giants Glaxo-Wellcome and Pfizer.

The nomination so infuriated the consumer watchdog group Public Citizen, that it has released a 135-page report onGraham.

Guest:

  • Joan Claybrook, President of Public Citizen.

Related links:


The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.

Make a donation